Annual Shareholders Equity
$24.82 M
-$17.50 M-41.36%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual stockholders equity is $24.82 million, with the most recent change of -$17.50 million (-41.36%) on April 30, 2024.
- During the last 3 years, IPA annual shareholders equity has fallen by -$21.55 million (-46.47%).
- IPA annual shareholders equity is now -57.34% below its all-time high of $58.18 million, reached on April 30, 2022.
Performance
IPA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$23.49 M
-$226.20 K-0.95%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly stockholders equity is $23.49 million, with the most recent change of -$226.20 thousand (-0.95%) on October 31, 2024.
- Over the past year, IPA quarterly shareholders equity has dropped by -$226.20 thousand (-0.95%).
- IPA quarterly shareholders equity is now -59.62% below its all-time high of $58.18 million, reached on April 30, 2022.
Performance
IPA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IPA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.4% | -0.9% |
| 3 y3 years | -46.5% | -0.9% |
| 5 y5 years | +84.8% | -0.9% |
IPA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.3% | at low | -59.6% | at low |
| 5 y | 5-year | -57.3% | +130.3% | -59.6% | +118.0% |
| alltime | all time | -57.3% | >+9999.0% | -59.6% | +9925.6% |
ImmunoPrecise Antibodies Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $23.49 M(-1.0%) |
| Jul 2024 | - | $23.72 M(-4.4%) |
| Apr 2024 | $24.82 M(-41.4%) | $24.82 M(-33.2%) |
| Jan 2024 | - | $37.17 M(-1.2%) |
| Oct 2023 | - | $37.62 M(-7.4%) |
| Jul 2023 | - | $40.62 M(-4.0%) |
| Apr 2023 | $42.32 M(-27.3%) | $42.32 M(-7.3%) |
| Jan 2023 | - | $45.63 M(+0.6%) |
| Oct 2022 | - | $45.37 M(-11.2%) |
| Jul 2022 | - | $51.10 M(-12.2%) |
| Apr 2022 | $58.18 M(+25.5%) | $58.18 M(+55.7%) |
| Jan 2022 | - | $37.37 M(-9.0%) |
| Oct 2021 | - | $41.07 M(-7.6%) |
| Jul 2021 | - | $44.43 M(-4.2%) |
| Apr 2021 | $46.37 M(+330.2%) | $46.37 M(+83.7%) |
| Jan 2021 | - | $25.24 M(+8.2%) |
| Oct 2020 | - | $23.33 M(+57.1%) |
| Jul 2020 | - | $14.85 M(+37.7%) |
| Apr 2020 | $10.78 M(-19.7%) | $10.78 M(-1.4%) |
| Jan 2020 | - | $10.93 M(-1.4%) |
| Oct 2019 | - | $11.09 M(-7.1%) |
| Jul 2019 | - | $11.94 M(-11.1%) |
| Apr 2019 | $13.43 M(+35.8%) | $13.43 M(-11.1%) |
| Jan 2019 | - | $15.11 M(-4.0%) |
| Oct 2018 | - | $15.73 M(+67.4%) |
| Jul 2018 | - | $9.40 M(-4.9%) |
| Apr 2018 | $9.89 M(+336.1%) | $9.89 M(+20.3%) |
| Jan 2018 | - | $8.22 M(-0.4%) |
| Oct 2017 | - | $8.26 M(+317.2%) |
| Jul 2017 | - | $1.98 M(-12.7%) |
| Apr 2017 | $2.27 M(-1409.5%) | $2.27 M(-22.5%) |
| Jan 2017 | - | $2.93 M(+1276.6%) |
| Sep 2016 | - | $212.50 K(-226.2%) |
| Jun 2016 | - | -$168.40 K(-6.4%) |
| Mar 2016 | - | -$180.00 K(+3.9%) |
| Dec 2015 | -$173.20 K(-3.6%) | - |
| Dec 2015 | - | -$173.20 K(+5.7%) |
| Sep 2015 | - | -$163.80 K(-2.4%) |
| Jun 2015 | - | -$167.80 K(-1.1%) |
| Mar 2015 | - | -$169.60 K(-5.6%) |
| Dec 2014 | -$179.60 K(+18.6%) | - |
| Dec 2014 | - | -$179.60 K(-8.6%) |
| Sep 2014 | - | -$196.40 K(+12.6%) |
| Jun 2014 | - | -$174.50 K(+22.0%) |
| Mar 2014 | - | -$143.00 K(-5.5%) |
| Dec 2013 | -$151.40 K(-30.2%) | - |
| Dec 2013 | - | -$151.40 K(+52.5%) |
| Sep 2013 | - | -$99.30 K(-58.5%) |
| Jun 2013 | - | -$239.10 K(+4.9%) |
| Mar 2013 | - | -$227.90 K(+5.1%) |
| Dec 2012 | -$216.80 K(+84.7%) | - |
| Dec 2012 | - | -$216.80 K(+29.7%) |
| Sep 2012 | - | -$167.10 K(+17.9%) |
| Jun 2012 | - | -$141.70 K(+11.8%) |
| Mar 2012 | - | -$126.70 K(+7.9%) |
| Dec 2011 | -$117.40 K(-174.1%) | - |
| Dec 2011 | - | -$117.40 K(+58.0%) |
| Sep 2011 | - | -$74.30 K(-404.5%) |
| Jun 2011 | - | $24.40 K(-81.1%) |
| Mar 2011 | - | $129.40 K(-18.3%) |
| Dec 2010 | $158.40 K | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $158.40 K(-96.9%) |
| Sep 2010 | - | $5.10 M(+1.9%) |
| Jun 2010 | - | $5.00 M(-5.3%) |
| Mar 2010 | - | $5.28 M(+2.5%) |
| Dec 2009 | $5.15 M(-6.4%) | - |
| Dec 2009 | - | $5.15 M(-17.3%) |
| Sep 2009 | - | $6.23 M(+8.0%) |
| Jun 2009 | - | $5.77 M(+8.0%) |
| Mar 2009 | - | $5.34 M(-3.0%) |
| Dec 2008 | $5.51 M(+7.3%) | - |
| Dec 2008 | - | $5.51 M(-13.9%) |
| Sep 2008 | - | $6.40 M(+31.9%) |
| Jun 2008 | - | $4.85 M(-0.1%) |
| Mar 2008 | - | $4.86 M(-5.4%) |
| Dec 2007 | $5.13 M(+10.2%) | - |
| Dec 2007 | - | $5.13 M(-2.8%) |
| Sep 2007 | - | $5.28 M(+6.7%) |
| Jun 2007 | - | $4.95 M(+5.7%) |
| Mar 2007 | - | $4.68 M(+0.5%) |
| Dec 2006 | $4.66 M(+38.5%) | - |
| Dec 2006 | - | $4.66 M(-8.0%) |
| Sep 2006 | - | $5.06 M(-0.8%) |
| Jun 2006 | - | $5.11 M(+53.5%) |
| Mar 2006 | - | $3.33 M(-1.1%) |
| Dec 2005 | $3.36 M(-4.4%) | - |
| Dec 2005 | - | $3.36 M(-0.5%) |
| Sep 2005 | - | $3.38 M(+0.8%) |
| Jun 2005 | - | $3.35 M(-2.3%) |
| Mar 2005 | - | $3.43 M(-2.4%) |
| Dec 2004 | $3.52 M(+227.6%) | - |
| Dec 2004 | - | $3.52 M(+101.4%) |
| Sep 2004 | - | $1.75 M(+9.4%) |
| Jun 2004 | - | $1.60 M(-3.6%) |
| Mar 2004 | - | $1.66 M(+54.2%) |
| Dec 2003 | $1.07 M(+95.4%) | - |
| Dec 2003 | - | $1.07 M(+3.4%) |
| Sep 2003 | - | $1.04 M(+59.9%) |
| Jun 2003 | - | $649.60 K(+4.8%) |
| Mar 2003 | - | $619.70 K(+12.7%) |
| Dec 2002 | $549.70 K(+27.0%) | - |
| Dec 2002 | - | $549.70 K(-15.5%) |
| Sep 2002 | - | $650.40 K(-7.6%) |
| Jun 2002 | - | $704.00 K(+44.6%) |
| Mar 2002 | - | $486.90 K(+12.4%) |
| Dec 2001 | $433.00 K(+147.9%) | - |
| Dec 2001 | - | $433.00 K(-6.8%) |
| Sep 2001 | - | $464.60 K(-8.9%) |
| Jun 2001 | - | $510.20 K(+260.3%) |
| Mar 2001 | - | $141.60 K(-18.9%) |
| Dec 2000 | $174.70 K(-35.9%) | - |
| Dec 2000 | - | $174.70 K(-12.5%) |
| Sep 2000 | - | $199.70 K(-8.5%) |
| Jun 2000 | - | $218.20 K(-12.3%) |
| Mar 2000 | - | $248.80 K(-8.8%) |
| Dec 1999 | $272.70 K(-73.9%) | - |
| Dec 1999 | - | $272.70 K(-73.9%) |
| Dec 1998 | $1.05 M(-47.6%) | - |
| Dec 1998 | - | $1.05 M(-47.6%) |
| Dec 1997 | $2.00 M(-24.5%) | - |
| Dec 1997 | - | $2.00 M |
| Dec 1996 | $2.65 M | - |
FAQ
- What is ImmunoPrecise Antibodies annual stockholders equity?
- What is the all time high annual shareholders equity for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual shareholders equity year-on-year change?
- What is ImmunoPrecise Antibodies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly shareholders equity year-on-year change?
What is ImmunoPrecise Antibodies annual stockholders equity?
The current annual shareholders equity of IPA is $24.82 M
What is the all time high annual shareholders equity for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual stockholders equity is $58.18 M
What is ImmunoPrecise Antibodies annual shareholders equity year-on-year change?
Over the past year, IPA annual stockholders equity has changed by -$17.50 M (-41.36%)
What is ImmunoPrecise Antibodies quarterly stockholders equity?
The current quarterly shareholders equity of IPA is $23.49 M
What is the all time high quarterly shareholders equity for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly stockholders equity is $58.18 M
What is ImmunoPrecise Antibodies quarterly shareholders equity year-on-year change?
Over the past year, IPA quarterly stockholders equity has changed by -$226.20 K (-0.95%)